Cutler Group LP Novo Nordisk A S Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	BUY	$87.78 - $105.45 $270,011 - $324,364	3,076 New	3,076 $318,000
Q3 2022 Oct 25, 2022	SELL	$95.28 - $116.93 $45,924 - $56,360	-482 Reduced 82.82%	100 $9,000
Q2 2022 Aug 04, 2022	SELL	$103.24 - $121.81 $198,633 - $234,362	-1,924 Reduced 76.78%	582 $64,000
Q1 2022 Apr 14, 2022	BUY	$93.1 - $112.54 $233,308 - $282,025	2,506 New	2,506 $278,000
Q4 2017 Jan 17, 2018	SELL	$47.53 - $53.73 $776,782 - $878,109	-16,343 Closed	0 $0
Q3 2017 Oct 17, 2017	BUY	$41.15 - $49.22 $672,514 - $804,402	16,343	16,343 $786,000

1,954

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $237B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.